SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Piramal Enterprises informs about acquisition

23 Jun 2021 Evaluate

The company had, through its letter dated 31st March, 2021, made a disclosure regarding the acquisition of 100% stake in Hemmo Pharmaceuticals (‘Hemmo’), for an aggregate cash consideration of Rs 775 crores and earn-outs linked to achievement of milestones, by Piramal Pharma (‘PPL’), subsidiary of the Company (‘Transaction’). Piramal Enterprises has informed that PPL has completed the acquisition of Hemmo on 22nd June, 2021 and the Transaction is now closed.

The above information is a part of company’s filings submitted to BSE.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×